Is this going to be another of those weeks where we hear nothing from Archer about the Nilvadipine Phase 3 results?
We are at the 8 month Anniversary of the wrap up of the study, which seems like enough time to tabulate results! Hope that doesn't mean they have run into a snag!
Similarly, we are at the 11 month Anniversary of the Chapter 7 filing! Just hope that means there is a plan in place for Rock Creek's future.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.